Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Alpna Seth

At a glance: Alpna Seth is Director at Keros Therapeutics (KROS). Their latest SEC Form 4, filed Jun 5, 2026, reported a sale of $28K. On file: 0 purchase lines ($0) and 1 sale line ($28K).

Disclosed holdings: about $116K of KROS stock: 9,767 shares reported on their latest Form 4 (filed Jun 5, 2026), valued at the Nov 19, 2026 close of $11.85. This counts only KROS shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Keros Therapeutics, Inc. (KROS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $28K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 5SEC KROSKeros Therapeutics, Inc. Sell Plan 2,6259,767 held (−21%) $10.72 $28K +10.5%
  • Sell

    Director Alpna Seth sold $28K of KROS at $10.72 — pre-scheduled 10b5-1 plan sale.

Follow Alpna Seth

Get one email when Alpna Seth files a new purchase or sale. Free.

At most one email a day about Alpna Seth, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.